March 3, 2021
Updated July 28, 2021
Carolyn Anderson, Simón-Ellebracht Professor in Medicinal Chemistry and professor of radiology at the University of Missouri, is a world-class radiopharmaceutical researcher who has devoted her career to improving diagnostic imaging and treating diseases such as cancer and sickle cell disease.
As part of the NextGen Precision Health initiative, Anderson and her lab will lead the Molecular Imaging and Theranostics Center in developing targeted radiopharmaceutical therapy agents, either alone or in combination with immune-based therapies, to battle melanoma and other types of cancer. The goal is to kill cancer cells with less damage to the body — improving the patient’s quality of life.